SCHEMBL6984736

SCHEMBL6984736

NC(=O)C1CCS(=O)(=O)N1

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GLI1 P08151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1613612 0.79 CYP2D6 (0.40)
SCHEMBL3741722 0.79 CYP2D6 (0.40)
SCHEMBL19919907 0.72
SCHEMBL19919497 0.72
SCHEMBL1764799 0.72 KMT2A (0.38)
SCHEMBL29493878 0.70 GLI1 (0.39) GLI1
SCHEMBL2031312 0.69 HRH3 (0.32)
SCHEMBL2028983 0.69 HRH3 (0.32)
SCHEMBL2702821 0.65
SCHEMBL13045000 0.65 GLI1 (0.32) GLI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071471-A Internal sulfonamide compounds and methods of use thereof 正大天晴药业集团股份有限公司 2018-12-21 CN disclosed
EP-1322627-A1 CYCLIC SULFONYL COMPOUNDS AS INHIBITORS OF METALLOPROTEASES Bristol-Myers Squibb Pharma Company (US) 2003-07-02 EP disclosed
WO-2002028846-A1 CYCLIC SULFONYL COMPOUNDS AS INHIBITORS OF METALLOPROTEASES DUPONT PHARMACEUTICALS COMPANY (US) 2002-04-11 WO disclosed